Sunshine Biopharma, Inc. (SBFM) vs Sonoma Pharmaceuticals, Inc. (SNOA)
Sunshine Biopharma, Inc. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $6.0M against $3.3M — 1.8× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against −2.74%. Sonoma Pharmaceuticals, Inc. has the higher net margin (−10.3% vs −16.5%) and the lower return on invested capital (−70.0% vs −26.7%). Across the 18 metrics below, Sonoma Pharmaceuticals, Inc. leads on 10 and Sunshine Biopharma, Inc. on 8.
Valuation
| Metric | SBFM | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.14 |
| P/S | 0.03 | 0.22 | 2.25 |
| P/B | 0.04 | 0.74 | 1.90 |
| Price to free cash flow | n/m | n/m | 16.54 |
| EV/EBITDA | 2.48 | 0.19 | 12.29 |
| EV/Sales | (0.34) | (0.01) | 2.56 |
| Earnings yield | (1,208.33%) | (96.06%) | (2.99%) |
| Free cash flow yield | (482.76%) | (54.36%) | 0.00% |
Profitability
| Metric | SBFM | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 30.30% | 38.91% | 53.94% |
| Operating margin | (16.65%) | (6.41%) | 0.00% |
| Net margin | (16.50%) | (10.33%) | 0.00% |
| Free cash flow margin | (15.66%) | (12.11%) | 0.00% |
| Return on equity | (21.93%) | (42.52%) | (0.40%) |
| Return on assets | (17.78%) | (13.85%) | (3.32%) |
| Return on invested capital | (26.67%) | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack